Back to Search
EFRAIN RIVERA, M.D.
M.D.
Interventional Pain Medicine Physician
NPI: 1780780858IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology Physician
Anesthesiology
Code: 207L00000X
G1525(TX)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
G1525(TX)
Education
BAYLOR COLLEGE OF MEDICINE
Class of 1981
Research & Publications (20)
Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
PMID 19088324·Oncologist·2008
6-review
Trends in recommendations of myelosuppressive chemotherapy for the treatment of breast cancer: evolution of the national comprehensive cancer network guidelines and the cooperative group studies.
PMID 16764742·Clin Breast Cancer·2006
4-observational
Current status of liposomal anthracycline therapy in metastatic breast cancer.
PMID 14667278·Clin Breast Cancer·2003
6-review
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.
PMID 12947059·J Clin Oncol·2003
3-trial
Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
PMID 11844821·J Clin Oncol·2002
3-trial
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
PMID 11914909·Cancer Chemother Pharmacol·2002
8-other
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
PMID 11251001·J Clin Oncol·2001
3-trial
Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
PMID 19675449·Am J Clin Oncol·2010
6-review
Implementation of different initiatives to develop a culture of professionalism in the medical school.
PMID 19530555·P R Health Sci J·2009
8-other
Study of kinetic parameters in a mechanistic model for bioethanol production through a screening technique and optimization.
PMID 19125302·Bioprocess Biosyst Eng·2009
8-other
Nitrosyl hydride (HNO) as an O2 analogue: long-lived HNO adducts of ferrous globins.
PMID 19368336·Biochemistry·2009
7-preclinical
Involvement of hydrogen peroxide in histamine-induced modulation of WM35 human malignant melanoma cell proliferation.
PMID 19285550·Free Radic Biol Med·2009
8-other
Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice.
PMID 19266598·World J Gastroenterol·2009
7-preclinical
Effect of histamine on the expression of metalloproteinases and cell adhesion in breast cancer cell lines.
PMID 19274436·Inflamm Res·2009
8-other
A comparison of experimental aneurysm occlusion determination by angiography, scanning electron microscopy, MICROFIL perfusion, and histology.
PMID 19582862·J Biomed Mater Res B Appl Biomater·2009
4-observational
Sequence and crowding effects in the aggregation of a 10-residue fragment derived from islet amyloid polypeptide.
PMID 19486677·Biophys J·2009
7-preclinical
A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
PMID 18544361·J Thorac Cardiovasc Surg·2008
4-observational
Expressive writing as a presurgical stress management intervention for breast cancer patients.
PMID 18544285·J Soc Integr Oncol·2008
4-observational
Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered from proteomic versus transcriptomic analysis.
PMID 18541473·J Proteomics·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1717 BROWN ST STE 3
EL PASO, TX 79902 - Phone
- (915) 261-7226
Quick Facts
- NPI
- 1780780858
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile